China's Creating Cheapo Versions of Ozempic That Could Majorly Shake Up the Market

As China prepares to beef up its weight loss medication market, the Danish firm that makes Ozempic and Wegovy may soon have its dominance threatened.Chinese drug manufacturers are working on creating at least 15 generic versions of the glucagon-like peptide-1 agonist drugs as Ozempic maker Novo Nordisk makes money hand over fist in the region., Novo saw the diabetes drug Ozempic sales in the country nearly double over the last few years, topping out at nearly $700 million.

I understand and agree that registration on or use of this site constitutes agreement to its User Agreement and Privacy Policy

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

China’s growing e-commerce market is creating a new set of winnersOnline shopping in China is widely expected to grow. It's less clear how much longtime players such as Alibaba and JD.com will benefit.
Sumber: CNBC - 🏆 12. / 72 Baca lebih lajut »